757 related articles for article (PubMed ID: 17315539)
1. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of the new alpha-1A-adrenergic receptor antagonist, phthalimide-phenylpiperazine analog (RWJ-69442), in rat, dog and human hepatic S9 fractions, and in rats.
Wu WN; McKown LA; Kuo GH
Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):113-20. PubMed ID: 16010870
[TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism of the new anxiolytic agent, RWJ-52763 in human hepatic S9 fraction-API-MS/MS identification of metabolites.
Wu WN; McKown LA; Reitz AB
J Pharm Biomed Anal; 2003 Feb; 31(1):95-102. PubMed ID: 12560053
[TBL] [Abstract][Full Text] [Related]
4. In-vitro metabolism of the new anxiolytic agent, RWJ-50172, in rat hepatic S9 fraction and microbial transformation in fungi, Cunninghamella sp.
Wu WN; McKown LA; Melton JL; Reitz AB
J Pharm Pharmacol; 2003 Aug; 55(8):1099-105. PubMed ID: 12956899
[TBL] [Abstract][Full Text] [Related]
5. Human hepatic metabolism of the anxiolytic agent, RWJ-51521--API-MS/MS identification of metabolites.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2004; 29(4):257-62. PubMed ID: 15726887
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of the new nonbenzodiazepine anxiolytic agent, RWJ-51204, in mouse, rat, dog, monkey and human hepatic S9 fractions, and in rats, dogs and humans.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2004; 29(4):263-8. PubMed ID: 15726888
[TBL] [Abstract][Full Text] [Related]
7. Hepatic metabolism of two alpha-1A-adrenergic receptor antagonists, phthalimide-phenylpiperazine analogs (RWJ-69205 and RWJ-69471), in the rat, dog and human.
Wu WN; McKown LA; Kuo GH
Eur J Drug Metab Pharmacokinet; 2006; 31(4):271-6. PubMed ID: 17315538
[TBL] [Abstract][Full Text] [Related]
8. In vitro biotransformation of the analgesic agent, RWJ-51784, in rat, dog and human.
Wu WN; McKown LA; Carson JR
Eur J Drug Metab Pharmacokinet; 2003; 28(2):107-11. PubMed ID: 12877567
[TBL] [Abstract][Full Text] [Related]
9. Hepatic biotransformation of the new calcium-mimetic agent, RWJ-68025, in the rat and in man--API-MS/MS identification of metabolites.
Wu WN; McKown LA; Rybczynski PJ; Demarest K
J Pharm Pharmacol; 2003 May; 55(5):631-7. PubMed ID: 12831505
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
11. In vitro biotransformation of the new antipsychotic agent, RWJ-46344 in rat hepatic S9 fraction: API-MS/MS/MS identification of metabolites.
Wu WN; McKown LA; Moyer MD; Reitz AB
J Pharm Biomed Anal; 2000 Dec; 24(2):307-16. PubMed ID: 11130209
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of the alpha-1A-adrenergic receptor antagonist, pyridine-phenylpiperazine analog (RWJ-69597), in rat, dog and human hepatic S9 fractions -API-MS/MS identification of metabolites.
Wu WN; McKown LA; Kuo GH
Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):105-11. PubMed ID: 16010869
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolism of BIIB021, an inhibitor of heat shock protein 90, in liver microsomes and hepatocytes of rats, dogs, and humans and recombinant human cytochrome P450 isoforms.
Xu L; Woodward C; Khan S; Prakash C
Drug Metab Dispos; 2012 Apr; 40(4):680-93. PubMed ID: 22217465
[TBL] [Abstract][Full Text] [Related]
14. In vitro identification of metabolic pathways and cytochrome P450 enzymes involved in the metabolism of etoperidone.
Yan Z; Caldwell GW; Wu WN; McKown LA; Rafferty B; Jones W; Masucci JA
Xenobiotica; 2002 Nov; 32(11):949-62. PubMed ID: 12487725
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism of the analgesic agent, RWJ-37874, in rat and human.
Wu WN; McKown LA; Carson JR
Eur J Drug Metab Pharmacokinet; 2003; 28(2):101-5. PubMed ID: 12877566
[TBL] [Abstract][Full Text] [Related]
16. In vitro metabolism of a new cardioprotective agent, KR-32570, in human liver microsomes.
Kim H; Kang S; Kim H; Yoon YJ; Cha EY; Lee HS; Kim JH; Yea SS; Lee SS; Shin JG; Liu KH
Rapid Commun Mass Spectrom; 2006; 20(5):837-43. PubMed ID: 16470676
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of pantoprazole involving conjugation with glutathione in rats.
Zhong D; Xie Z; Chen X
J Pharm Pharmacol; 2005 Mar; 57(3):341-9. PubMed ID: 15807990
[TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism of l-corydalmine, a potent analgesic drug, in human, cynomolgus monkey, beagle dog, rat and mouse liver microsomes.
Tang X; Di X; Zhong Z; Xie Q; Chen Y; Wang F; Ling Z; Xu P; Zhao K; Wang Z; Liu L; Liu X
J Pharm Biomed Anal; 2016 Sep; 128():98-105. PubMed ID: 27239758
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of oxymetazoline: evidence for bioactivation to a reactive metabolite.
Mahajan MK; Uttamsingh V; Daniels JS; Gan LS; LeDuc BW; Williams DA
Drug Metab Dispos; 2011 Apr; 39(4):693-702. PubMed ID: 21177487
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism studies of nomifensine monooxygenation pathways: metabolite identification, reaction phenotyping, and bioactivation mechanism.
Yu J; Brown DG; Burdette D
Drug Metab Dispos; 2010 Oct; 38(10):1767-78. PubMed ID: 20595377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
